Athelas Stock

Athelas - rapid diagnostics through Deep Learning.

Sign up today and learn more about Athelas Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Athelas Stock

Athelas utilizes deep learning and computer vision to rapidly analyze tissue samples for diagnostics. The product is used for immune monitoring, blood counts, and parasite diagnostics.

Funding History

February 2016$0
August 2016$120K
January 2017$3.5M

Management

Founder

Tanay Tandon

Product Manager

Steve Moffatt

Press

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo